<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for GILD</title>
    <link />
    <description>Headlines for Gilead Sciences</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447611-gilead-sciences-management-presents-at-the-2013-ubs-global-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 13:34:03 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928285/1/5-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Leukemia's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/tackling-cancer-leukemias-biggest-current-upcoming/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/3-horrendous-health-care-stocks-this-week-28/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/gilead-sciences-to-present-at-the-2013-ubs-global-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 16:20:50 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Lightning Round - I've Had It With Magnum Hunter (5/16/13)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1443001-cramer-s-lightning-round-i-ve-had-it-with-magnum-hunter-5-16-13.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 17 May 2013 06:20:48 GMT</pubDate>
    </item>
    <item>
      <title>'Mad Money' Lightning Round: Magnum Hunter Blew It</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11925148/1/mad-money-lightning-round-magnum-hunter-blew-it.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 17 May 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Pipeline Progress at Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99568/pipeline-progress-at-gilead.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 16 May 2013 14:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Meeting Highlights the Good and Bad of the Immune System</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/cancer-meeting-highlights-the-good-and-bad-of-the/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 19:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lym</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/gilead-announces-response-data-from-phase-2-study-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 18:50:47 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Offers Response Data from Phase 2 Study of Idelalisib</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3594218/gilead-offers-response-data-from-phase-2-study-of-idelalisib.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 18:32:47 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13 Preview: Gilead's Big Cancer Debut</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924167/1/asco-13-preview-gileads-big-cancer-debut.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ASCO '13 Preview: Roche's Next-Gen Rituxan Steps Up</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11924149/1/asco-13-preview-roches-next-gen-rituxan-steps-up.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 18:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Racing Toward the Next Hepatitis C Drug Approval</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/racing-toward-the-next-hepatitis-c-drug-approval/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 18:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wedne</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/gilead-sciences-to-present-at-the-bank-of-america-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 16:35:14 GMT</pubDate>
    </item>
    <item>
      <title>Should You Buy Stock in Gilead After the Earnings Miss?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/should-you-buy-stock-in-gilead-after-the-earnings/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 14:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Market News for May 14, 2013 - Market News</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99289/stock-market-news-for-may-14-2013.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 09:36:01 GMT</pubDate>
    </item>
    <item>
      <title>The 8 Biggest Health Problems Americans Face</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/13/the-8-biggest-health-problems-americans-face/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 13 May 2013 19:17:00 GMT</pubDate>
    </item>
    <item>
      <title>FDA Prioritizes New Hepatitis C Drug</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/13/fda-prioritizes-new-hepatitis-c-drug/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 13 May 2013 18:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences Inc (GILD): Today's Featured Health Care Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11921996/1/gilead-sciences-inc-gild-todays-featured-health-care-winner.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 13 May 2013 17:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
